BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23260199)

  • 1. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
    Gocha AR; Nuovo G; Iwenofu OH; Groden J
    Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
    Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
    Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
    Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
    Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative lengthening of telomeres does exist in various canine sarcomas.
    Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
    Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
    Claude E; Decottignies A
    Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
    Mangosh TL; Grabowska MM; Taylor DJ
    Prostate; 2021 Nov; 81(15):1235-1251. PubMed ID: 34492133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The telomere maintenance mechanism spectrum and its dynamics in gliomas.
    Kim S; Chowdhury T; Yu HJ; Kahng JY; Lee CE; Choi SA; Kim KM; Kang H; Lee JH; Lee ST; Won JK; Kim KH; Kim MS; Lee JY; Kim JW; Kim YH; Kim TM; Choi SH; Phi JH; Shin YK; Ku JL; Lee S; Yun H; Lee H; Kim D; Kim K; Hur JK; Park SH; Kim SK; Park CK
    Genome Med; 2022 Aug; 14(1):88. PubMed ID: 35953846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALT: A Multi-Faceted Phenomenon.
    Sommer A; Royle NJ
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
    Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
    Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
    Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
    Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in pleural malignant mesotheliomas.
    Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
    Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas.
    Yan P; Benhattar J; Coindre JM; Guillou L
    Int J Cancer; 2002 Apr; 98(6):851-6. PubMed ID: 11948462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable assessment of telomere maintenance mechanisms in neuroblastoma.
    Meeser A; Bartenhagen C; Werr L; Hellmann AM; Kahlert Y; Hemstedt N; N├╝rnberg P; Altm├╝ller J; Ackermann S; Hero B; Simon T; Peifer M; Fischer M; Rosswog C
    Cell Biosci; 2022 Sep; 12(1):160. PubMed ID: 36153564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.